Beerse, Belgium

Giustino Di Pretoro

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Janssen Pharmaceutica Nv, Protagonist Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giustino Di Pretoro. Retrieved from https://idiyas.com/inventor/giustino-di-pretoro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giustino Di Pretoro: Innovator in Autoimmune Treatment

Introduction

Giustino Di Pretoro is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of autoimmune inflammation through his innovative research and development of peptide inhibitors.

Latest Patents

Giustino holds 1 patent for his work titled "Compositions of peptide inhibitors of Interleukin-23 receptor." This invention relates to compositions of peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt or solvate forms thereof. The corresponding pharmaceutical compositions, methods, and uses are aimed at treating autoimmune inflammation and related diseases and disorders.

Career Highlights

Throughout his career, Giustino has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica NV and Protagonist Therapeutics, Inc. His experience in these organizations has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Giustino has collaborated with esteemed colleagues such as Dajun Sun and Gopal Rajan. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Giustino Di Pretoro's innovative contributions to the field of autoimmune treatment highlight his dedication to advancing medical science. His work continues to influence the development of effective therapies for autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…